Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-12-08
1996-11-26
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514369, 514370, 514374397', 548187, 548194, 548204, 548236, 548525, C07D40912, A61K 31425
Patent
active
055786197
ABSTRACT:
This invention relates to compounds of Formula I and the stereoisomers and pharmaceutically acceptable salts thereof ##STR1## wherein R is alkyl, alkenyl, alkynyl, or (CH.sub.2).sub.m R.sup.3 where R.sup.3 is cycloalkyl and m is 1 or 2;
REFERENCES:
patent: 4778903 (1988-10-01), Miyano
patent: 4889871 (1989-12-01), Djuric
patent: 5073562 (1991-12-01), Djuric
N. Ahmadzadeh, et al. Inflammation 15:497-503 (1991) "Relationship Between Leukotriene B.sub.4 and Immunological Parameters in Rheumatoid Synovial Fluids".
R. Barr et al. Prostaglandins 28:57-65 (1994) "The Analysis of Arachidonic Acid Metabolites in Normal, Uninvolved and Lesional Psoriatic Skin".
J. Drummond, et al. Tetrahedron Letters 29:1653-1656 (1988) "Convenient Procedure for the Preparation of Alkyl and Aryl Substituted N-(Aminoalkylacyl) Sulfonamides".
D. Fretland, et al. Prostaglandins Leukotrienes and Essential Fatty Acids 45:249-257 (1992) "Potential Role of Prostaglandins and Leukotrienes in Multiple Sclerosis and Experimental Allergic Encephalomyelitis".
V. Matassa, et al. J. Med. Chem. 33:1781-1790 "Evolution of a Series of Peptidoleukotriene Antagonists: Synthesis and Structure/Activity Relationships of 1,3,5-Substituted Indoles and Indazoles" 1990).
S. Rae, et al. The Lancet 2:1122-1123 (1982), "Leukotriene B.sub.4, an Inflammatory Mediator in Gout".
T. Schaar, et al. Journal of Medicinal Chemistry 22:1340-1346 (1979), "Synthesis and Biological Activity of Carboxyl-Terminus Modified Prostaglandin Analogues".
P. Sharon, et al. Gastroenterology, 86:453-460 (1984), "Enhanced Synthesis of Leukotriene B.sub.4 by Colonic Mucosa in Inflammatory Bowel Disease".
K. Shindo, et al. Journal of Internal Medicine, 228:91-96 (1990), "Measurement of leukotriene B.sub.4 in arterial bllod of asthmatic patients during wheezing attacks".
Djuric Stevan W.
Penning Thomas D.
LandOfFree
Alkoxy-substituted dihydrobenzopyran-2-sulfonimides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkoxy-substituted dihydrobenzopyran-2-sulfonimides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkoxy-substituted dihydrobenzopyran-2-sulfonimides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1973475